← Back to Clinical Trials
Recruiting NCT06839820
Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease
Trial Parameters
Condition Infliximab
Sponsor University Hospital, Akershus
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 1 Year
Max Age 18 Years
Start Date 2025-02-01
Completion 2026-04
All Conditions
Interventions
Infusion rate of infliximab
Brief Summary
OBJECTIVES OF THE STUDY 1. Investigate whether there are just as few infusion reactions with infliximab infusions of 60 min and 30 min. 2. Investigate patient and nurse satisfaction with infusions of 60 min and 30 min. 3. Investigate resource use in terms of total length of stay and use of nursing resources.
Eligibility Criteria
Inclusion Criteria: * Pediatric IBD patients on infliximab * 1-17 years * Received at least 5 infusions of infliximab prior to entry in the study Exclusion Criteria: * Receiving infliximab for non-IBD condition (reumatological or other causes) * previous severe infliximab infusion reaction * need for an interpreter * heart failure with hemodynamic impact * unwillingness to participate